Bettina M. Cockroft - 03 May 2023 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
03 May 2023
Net transactions value
$0
Form type
3
Filing time
09 May 2023, 17:10:19 UTC
Previous filing
13 Jun 2022
Next filing
10 Aug 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney